Amneal Pharmaceuticals of New York, LLC 2023-05-31 Health moderate FDA
Health · FDA · Recall #FDA-D-0756-2023
Methylprednisolone Acetate Injectable Suspension, USP 80 mg/mL, For Intramuscular,… Recall
Issued May 31, 2023 · Amneal Pharmaceuticals of New York, LLC
In May 2023, Amneal Pharmaceuticals of New York, LLC recalled the Methylprednisolone Acetate Injectable Suspension, USP 80 mg/mL, For Intramuscular,…, a moderate health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Labeling: Not Elsewhere Classified; A typographical error was observed in the NDC number on the preprinted Individual Folding Cartons (secondary packaging only). Incorrect NDC Number 70121-1573-1; Correct NDC Number 70121-1574-1.
What you should do
- 1 Stop using Methylprednisolone Acetate Injectable Suspension, USP 80 mg/mL, For Intramuscular,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Amneal Pharmaceuticals of New York, LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Amneal Pharmaceuticals of New York, LLC
- Category
- Health
- Recall date
- May 31, 2023
- Units affected
- Not reported
- Sold at
- Nationwide in the USA and PR
- Recall number
- FDA-D-0756-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Amneal Pharmaceuticals of New York, LLC has 4 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.